NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

CompletedNA

Sponsor: University of Virginia

Conditions: Diabetes Mellitus, Type 1

Interventions: CLC

Countries: United States

The purpose of this study is to use an investigational type of technology called Closed-Loop Control (CLC) Medical Platform System to help control blood sugar in people with type 1 diabetes mellitus in a home setting.

Eligibility overview

Sex: ALL

Age: 18 Years to 70 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* type 1 diabetes for at least one year
* using insulin for at least 1 year
* an insulin pump for at least 6 months
* willingness to switch to lispro (Humalog) or aspart (Novolog) if using glulisine (Apidra).

Exclusion Criteria:

* a medical condition or being been treated with medications that might interfere with the study

Locations (1)

Charlottesville, Virginia, United States